Healthcare Mutual Funds in India

Compare the mandate, the mix between domestic pharma and hospitals or diagnostics, how much sits in the largest holdings, the manager's tenure and the expense ratio. Cambridge Wealth provides scheme information covering these. Performance over a full cycle is more informative than a single strong year.

A pharma fund concentrates on drug manufacturers, including export-driven generics businesses exposed to US pricing and regulatory cycles. A broader healthcare fund adds hospitals, diagnostics and medical devices, which respond more to domestic demand. The two can behave quite differently in the same period.

Cambridge Wealth lists a Healthcare Long-Short Equity AIF — Category III, Global Healthcare & Pharma SIF and Pharmaceuticals Equity Long-Short SIF. Depending on the product, exposure may include pharmaceuticals, hospitals, diagnostics, life sciences, APIs, CRAMS, specialty generics and regulated-market exporters, with long and short positioning available in relevant strategies.

The stated minimum investment across the listed SIFs is Rs 10,00,000. For the Healthcare Long-Short Equity AIF — Category III, where a minimum is displayed on the platform, it is Rs 1,00,00,000. Applicable requirements, fees and investor eligibility should be confirmed in the relevant offer documents and private placement memorandum.

Yes. The Category III AIF may use leverage and derivatives, enabling both long and short equity positions. The SIF strategies also describe long and short positioning. These features can increase complexity and volatility, particularly in sector-concentrated healthcare portfolios, so investors should review the relevant risk disclosures and fund documents carefully.

Cambridge Wealth describes a 108-point institutional diligence process covering fundamentals, valuation, macro positioning and risk, with quarterly re-assessment. Investors can also access scheme information, quarterly review and portfolio tracking through app and web platforms. Fund-level reporting, fees, redemption terms and disclosures remain governed by the respective manager and scheme documents.